Position in VNDA
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$320,339
+$91,522 QoQ
Shares Held
52,343
+58.1% QoQ
Ownership
0.087%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#71
of 172 holders
Holding Since
Jun 2020
25 quarters on record
Voting authority
Sole 35%
Shared 0%
None 65%
Common Shares in VNDA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026MARTINGALE ASSET MANAGEMENT L P holds $144,833,314 across 62 Biotechnology names. VNDA ranks #53 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
42,729 | $21,224,776 | |
| 2 | INCY |
Incyte Corp
|
168,818 | $19,137,208 | |
| 3 | JAZZ |
Jazz Pharmaceuticals plc
|
59,492 | $14,335,787 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
18,953 | $11,817,953 | |
| 5 | LGND |
Ligand Pharmaceuticals Inc
|
17,562 | $5,551,172 | |
| 6 | ACAD |
Acadia Pharmaceuticals Inc
|
167,893 | $4,247,692 | |
| 7 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
13,634 | $4,104,243 | |
| 8 | INVA |
Innoviva, Inc.
|
165,115 | $3,749,761 |
All Filings in VNDA
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $320,339 | 52,343 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $228,817 | 33,114 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $292,065 | 33,114 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $88,238 | 17,683 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $94,791 | 20,083 | Shares | Sole | 2025-08-11 | |
| 2025-03-31 | $105,152 | 22,909 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $310,435 | 64,809 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $328,342 | 70,009 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $426,659 | 75,515 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $310,366 | 75,515 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $305,966 | 72,504 | Shares | Sole | 2024-02-12 | |
| 2023-09-30 | $346,559 | 80,222 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $441,345 | 66,972 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $330,462 | 48,669 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $585,028 | 79,165 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $757,252 | 76,645 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $267,246 | 24,518 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $338,372 | 29,918 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $1,199,280 | 76,436 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $1,370,103 | 79,936 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $1,424,736 | 66,236 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $1,023,402 | 68,136 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $817,662 | 62,227 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $531,531 | 55,024 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $1,138,554 | 99,524 | Shares | Sole | 2020-08-10 | |
| No filing history on record for this holder in this stock. | ||||||